Korean J healthc assoc Infect Control Prev.  2022 Dec;27(2):125-133. 10.14192/kjicp.2022.27.2.125.

Strategies for Minimizing Mealses Transmission in Korean Healthcare Facilities

• Kim YC

• KMID: 2537073
• DOI: http://doi.org/10.14192/kjicp.2022.27.2.125

Abstract

The introduction of a second dose of the measles vaccine has facilitated a significant reduction in the global measles burden. However, measles remains a disease with high morbidity and mortality rates in many countries, particularly those with low vaccination rates. In addition, several countries which had previously achieved measles elimination have experienced a resurgence of measles, as verified by the World Health Organization. A global measles outbreak between 2018 and 2019 resulted in the largest number of cases since 1996. During this period, several small-sized outbreaks, in which healthcare facilities facilitated measles transmission, were reported in South Korea. Because of the enclosed and crowded settings of hospitals, nosocomial transmission can play an important role in the current measles epidemiology. Therefore, strategies are necessary to minimize nosocomial transmission and control measles outbreaks. Herein, I review the characteristics of measles transmission in hospitals and introduce several strategies to promote the prevention and control of measles in healthcare facilities.

Keyword

Measles; Health facilities; Infection control

Reference

1. Moss WJ. 2017; Measles. Lancet. 390:2490–502. DOI: 10.1016/S0140-6736(17)31463-0. PMID: 28673424. PMCID: PMC9579355.

2. Wolfson LJ, Strebel PM, Gacic-Dobo M, Hoekstra EJ, McFarland JW, Hersh BS. 2007; Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study. Lancet. 369:191–200. DOI: 10.1016/S0140-6736(07)60107-X. PMID: 17240285.

3. Patel MK, Dumolard L, Nedelec Y, Sodha SV, Steulet C, Gacic-Dobo M, et al. 2019; Progress toward regional measles elimination - worldwide, 2000-2018. MMWR Morb Mortal Wkly Rep. 68:1105–11. DOI: 10.15585/mmwr.mm6848a1. PMID: 31805033. PMCID: PMC6897527.

4. Choe YJ, Jee Y, Oh MD, Lee JK. 2015; Measles elimination activities in the Western Pacific Region: experience from the Republic of Korea. J Korean Med Sci. 30 Suppl 2:S115–21. DOI: 10.3346/jkms.2015.30.S2.S115. PMID: 26617443. PMCID: PMC4659862.

5. Patel MK, Goodson JL, Alexander JP Jr, Kretsinger K, Sodha SV, Steulet C, et al. 2020; Progress toward regional measles elimination - worldwide, 2000-2019. MMWR Morb Mortal Wkly Rep. 69:1700–5. DOI: 10.15585/mmwr.mm6945a6. PMID: 33180759. PMCID: PMC7660667.

6. Choi S, Cho EH. 2020; Analysis of the occurrence of measles in Korea, 2019. Public Health Wkly Rep. 13:2445–58.

7. Choi WS, Sniadack DH, Jee Y, Go UY, So JS, Cho H, et al. 2011; Outbreak of measles in the Republic of Korea, 2007: importance of nosocomial transmission. J Infect Dis. 204(Suppl 1):S483–90. DOI: 10.1093/infdis/jir087. PMID: 21666204.

8. Yang TU, Kim JW, Eom HE, Oh HK, Kim ES, Kang HJ, et al. 2015; Resurgence of measles in a country of elimination: interim assessment and current control measures in the Republic of Korea in early 2014. Int J Infect Dis. 33:12–4. DOI: 10.1016/j.ijid.2014.09.016. PMID: 25447718.

9. Chen SY, Anderson S, Kutty PK, Lugo F, McDonald M, Rota PA, et al. 2011; Health care-associated measles outbreak in the United States after an importation: challenges and economic impact. J Infect Dis. 203:1517–25. DOI: 10.1093/infdis/jir115. PMID: 21531693.

10. Rota PA, Moss WJ, Takeda M, de Swart RL, Thompson KM, Goodson JL. 2016; Measles. Nat Rev Dis Primers. 2:16049. DOI: 10.1038/nrdp.2016.49. PMID: 27411684.

11. Chen RT, Goldbaum GM, Wassilak SG, Markowitz LE, Orenstein WA. 1989; An explosive point-source measles outbreak in a highly vaccinated population. Modes of transmission and risk factors for disease. Am J Epidemiol. 129:173–82. DOI: 10.1093/oxfordjournals.aje.a115106. PMID: 2910058.

12. Centers for Disease Control. Epidemiology and prevention of vaccine-preventable diseases. The pink book. https://www.cdc.gov/vaccines/pubs/pinkbook/meas.html. Updated on August 2021.

13. Richardson M, Elliman D, Maguire H, Simpson J, Nicoll A. 2001; Evidence base of incubation periods, periods of infectiousness and exclusion policies for the control of communicable diseases in schools and preschools. Pediatr Infect Dis J. 20:380–91. DOI: 10.1097/00006454-200104000-00004. PMID: 11332662.

14. Kim YC, Choi YH. 2019; Current and prospect on measles outbreak. Korean J Med. 94:237–45. DOI: 10.3904/kjm.2019.94.3.237.

15. Perry RT, Halsey NA. 2004; The clinical significance of measles: a review. J Infect Dis. 189 Suppl 1:S4–16. DOI: 10.1086/377712. PMID: 15106083.

16. Korea Centers for Disease Control. Infectious diseases surveillance yearbook, 2014. https://www.kdca.go.kr/npt/biz/npp/portal/nppPblctDtaView.do?pblctDtaSeAt=1&pblctDtaSn=18. Updated on June 2015.

17. Thompson KM. 2016; Evolution and use of dynamic transmission models for measles and rubella risk and policy analysis. Risk Anal. 36:1383–403. DOI: 10.1111/risa.12637. PMID: 27277138.

18. Fu J, Jiang C, Wang J, Cai R, Cheng W, Shi L, et al. 2019; A hospital-associated measles outbreak in health workers in Beijing: implications for measles elimination in China, 2018. Int J Infect Dis. 78:85–92. DOI: 10.1016/j.ijid.2018.10.023. PMID: 30391419.

19. Gohil SK, Okubo S, Klish S, Dickey L, Huang SS, Zahn M. 2016; Healthcare workers and post-elimination era measles: lessons on acquisition and exposure prevention. Clin Infect Dis. 62:166–72. DOI: 10.1093/cid/civ802. PMID: 26354971. PMCID: PMC4723666.

20. Hahné SJ, Nic Lochlainn LM, van Burgel ND, Kerkhof J, Sane J, Yap KB, et al. 2016; Measles outbreak among previously immunized healthcare workers, the Netherlands, 2014. J Infect Dis. 214:1980–6. DOI: 10.1093/infdis/jiw480. PMID: 27923955.

21. Jia H, Ma C, Lu M, Fu J, Rodewald LE, Su Q, et al. 2018; Transmission of measles among healthcare workers in Hospital W, Xinjiang Autonomous Region, China, 2016. BMC Infect Dis. 18:36. DOI: 10.1186/s12879-018-2950-y. PMID: 29329528. PMCID: PMC5767050.

22. Song K, Lee JM, Lee EJ, Lee BR, Choi JY, Yun J, et al. 2022; Control of a nosocomial measles outbreak among previously vaccinated adults in a population with high vaccine coverage: Korea, 2019. Eur J Clin Microbiol Infect Dis. 41:455–66. DOI: 10.1007/s10096-021-04390-4. PMID: 34999974.

23. Remington PL, Hall WN, Davis IH, Herald A, Gunn RA. 1985; Airborne transmission of measles in a physician's office. JAMA. 253:1574–7. DOI: 10.1001/jama.1985.03350350068022. PMID: 3974036.

24. Beggs CB, Shepherd SJ, Kerr KG. 2010; Potential for airborne transmission of infection in the waiting areas of healthcare premises: stochastic analysis using a Monte Carlo model. BMC Infect Dis. 10:247. DOI: 10.1186/1471-2334-10-247. PMID: 20727178. PMCID: PMC2939637.

25. Botelho-Nevers E, Gautret P, Biellik R, Brouqui P. 2012; Nosocomial transmission of measles: an updated review. Vaccine. 30:3996–4001. DOI: 10.1016/j.vaccine.2012.04.023. PMID: 22521843.

26. Biellik RJ, Clements CJ. 1997; Strategies for minimizing nosocomial measles transmission. Bull World Health Organ. 75:367–75. PMID: 9342896. PMCID: PMC2486960.

27. Fiebelkorn AP, Redd SB, Kuhar DT. 2015; Measles in healthcare facilities in the United States during the postelimination era, 2001-2014. Clin Infect Dis. 61:615–8. DOI: 10.1093/cid/civ387. PMID: 25979309. PMCID: PMC4646220.

28. Park JW, Yu SN, Park E, Lee Y, Park SM, Jeon MH. 2019; Modified measles in an anti-measles immunoglobulin G-negative healthcare worker who had received two doses of measles-containing vaccine. Infect Chemother. 51:305–9. DOI: 10.3947/ic.2019.51.3.305. PMID: 31583864. PMCID: PMC6779578.

29. Chang HH, Kim SW, Kwon KT, Kim HI, Kim MJ, Ryu SY, et al. 2019; Preliminary report of seroprevalence of anti-measles immunoglobulin G among healthcare workers of 6 teaching hospitals of Daegu, Korea in 2019. Infect Chemother. 51:54–7. DOI: 10.3947/ic.2019.51.1.54. PMID: 30941938. PMCID: PMC6446006.

30. Jung J, Kim SK, Kwak SH, Hong MJ, Kim SH. 2019; Seroprevalence of measles in healthcare workers in South Korea. Infect Chemother. 51:58–61. DOI: 10.3947/ic.2019.51.1.58. PMID: 30941939. PMCID: PMC6446017.

31. Kwak YG, Song JE, Oh GB, Jeong IH, Cho CR, Kim N, et al. 2020; Comparison of the seroprevalence of measles antibodies among healthcare workers in two Korean hospitals in 2019. Infect Chemother. 52:93–7. DOI: 10.3947/ic.2020.52.1.93. PMID: 31997601. PMCID: PMC7113453.

32. Han SB, Park SH, Yi Y, Ji SK, Jang SH, Park MH, et al. 2021; Measles seroprevalence among healthcare workers in South Korea during the post-elimination period. Hum Vaccin Immunother. 17:2517–21. DOI: 10.1080/21645515.2021.1888623. PMID: 33689571. PMCID: PMC8475616.

33. Kim CJ, Bae JY, Jun KI, Chung HS, Kim A, Kim J, et al. 2021; Risk of absence of measles antibody in healthcare personnel and efficacy of booster vaccination. Vaccines (Basel). 9:501. DOI: 10.3390/vaccines9050501. PMID: 34066145. PMCID: PMC8151488.

34. Yoo Y, Park WJ, Cho S, Lim DY, Kim S, Kang W, et al. 2021; Seroprevalence of measles, mumps, rubella, and varicella-zoster antibodies in new female nurses in the Republic of Korea. Ann Occup Environ Med. 33:e19. DOI: 10.35371/aoem.2021.33.e19. PMID: 34754480. PMCID: PMC8264122.

35. Lee JS, Jeong O, Yang H. 2021; Screening and vaccination against measles and varicella among health care workers: a cost-effectiveness analysis. Asia Pac J Public Health. 33:508–15. DOI: 10.1177/10105395211026468. PMID: 34165349.

36. Steingart KR, Thomas AR, Dykewicz CA, Redd SC. 1999; Transmission of measles virus in healthcare settings during a communitywide outbreak. Infect Control Hosp Epidemiol. 20:115–9. DOI: 10.1086/501595. PMID: 10064215.

37. Korea Centers for Disease Control. 2018. Guidelines for adult immunization. 2nd ed. Korea Centers for Disease Control and Prevention;Cheongju: p. 40–1. DOI: 10.1086/501595.

38. Uzicanin A, Zimmerman L. 2011; Field effectiveness of live attenuated measles-containing vaccines: a review of published literature. J Infect Dis. 204 Suppl 1:S133–48. DOI: 10.1093/infdis/jir102. PMID: 21666154.

39. De Serres G, Boulianne N, Defay F, Brousseau N, Benoît M, Lacoursière S, et al. 2012; Higher risk of measles when the first dose of a 2-dose schedule of measles vaccine is given at 12-14 months versus 15 months of age. Clin Infect Dis. 55:394–402. DOI: 10.1093/cid/cis439. PMID: 22543023.

40. Yeung LF, Lurie P, Dayan G, Eduardo E, Britz PH, Redd SB, et al. 2005; A limited measles outbreak in a highly vaccinated US boarding school. Pediatrics. 116:1287–91. DOI: 10.1542/peds.2004-2718. PMID: 16322148.

41. Fiebelkorn AP, Coleman LA, Belongia EA, Freeman SK, York D, Bi D, et al. 2016; Measles virus neutralizing antibody response, cell-mediated immunity, and immunoglobulin G antibody avidity before and after receipt of a third dose of measles, mumps, and rubella vaccine in young adults. J Infect Dis. 213:1115–23. DOI: 10.1093/infdis/jiv555. PMID: 26597262. PMCID: PMC5729920.

42. Korea Centers for Disease Control. Mealses response guideline. https://www.kdca.go.kr/board/board.es?mid=a20507020000&bid=0019. Updated on July 2019.

43. Korea Disease Control. Guideline on diagnostic test for legal communicable diseases. https://kdca.go.kr/board/board.es?mid=a20507020000&bid=0019. Updated on December 2021.

44. Warrener L, Slibinskas R, Chua KB, Nigatu W, Brown KE, Sasnauskas K, et al. 2011; A point-of-care test for measles diagnosis: detection of measles-specific IgM antibodies and viral nucleic acid. Bull World Health Organ. 89:675–82. DOI: 10.2471/BLT.11.088427. PMID: 21897488. PMCID: PMC3165981.

45. Centers for Disease Control. Interim infection prevention and control recommendations for measles in healthcare settings. https://www.cdc.gov/infectioncontrol/guidelines/measles/index.html. Updated on July 2019.

46. Rutala WA, Weber DJ. 2013; Disinfection and sterilization: an overview. Am J Infect Control. 41(5 Suppl):S2–5. DOI: 10.1016/j.ajic.2012.11.005. PMID: 23622742.

47. World Health Organization. 2020. Measles and rubella strategic framework: 2021-2030. World Health Organization;Geneva: p. 7. DOI: 10.1016/j.ajic.2012.11.005.

48. Dixon MG, Ferrari M, Antoni S, Li X, Portnoy A, Lambert B, et al. 2021; Progress toward regional measles elimination - worldwide, 2000-2020. MMWR Morb Mortal Wkly Rep. 70:1563–9. DOI: 10.15585/mmwr.mm7045a1. PMID: 34758014. PMCID: PMC8580203.